Biotech PE to Healthcare IBD?

Ladies and gentlemen of WSO, I could really appreciate your input on what you would do in my situation.

I'm posting in the investment banking forum because I'm considering trying to lateral to bb/mm ibd from my pe role. If you have other ideas please let me know.

I'm in a very small VC firm, focused on investing in biotech startups (early stage, pre revenue). It was my dream job, but things went south shortly after I joined and long story short I'm now the only person in the "investing team" (everyone else works in a function e.g. legal / finance or is the CEO). Also the fund is now closed (not what was sold to me when taking the job).

Most days a lot of people work from home, so I'm often the only person in the office which is pretty boring. It's difficult for me to lateral to a better fund because competition for these roles is high and most have a PhD in life sciences and I only have a bachelors.

I'm therefore thinking the best route forward would be healthcare m&a to basically gain more transaction exposure and industry contacts. Also considering research but ultimately I want to end back in pe anyway at somewhere more established, so I'm thinking m&a may be a better route.

Thanks for any help!

1 Comments
 

Natus voluptatem voluptas odit sed. Quis qui necessitatibus harum et eveniet. Itaque impedit in ut. Necessitatibus mollitia pariatur voluptatem numquam fuga sit temporibus.

Omnis temporibus cum explicabo earum. Quia dolorem et asperiores qui. Eaque ut eos quis hic quos commodi. Qui dolore quod voluptatum est nesciunt. Tenetur enim necessitatibus eos velit quidem veniam sequi. Ex et corrupti ea facilis necessitatibus incidunt.

Tempore esse laudantium recusandae enim at. Ducimus explicabo eum magni unde nesciunt harum doloribus.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Guggenheim Partners 01 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 03 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
CompBanker's picture
CompBanker
98.9
9
dosk17's picture
dosk17
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”